A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/715 (2006.01) A61K 31/70 (2006.01) A61K 31/721 (2006.01) A61P 31/04 (2006.01)
Patent
CA 2180352
Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use of dextran or dextran sulphate as the active ingredient.
Procédés destinés à réduire ou à prévenir le risque d'infection par des germes pathogènes bactériens in vivo. L'invention concerne notamment un procédé destiné à réduire le risque d'infection à <u>P. Aeruginosa</u> in vivo chez les hôtes dont les mécanismes de défense sont déficients, tels que des malades atteints de la mucoviscidose. Selon ces procédés, le dextrane ou le sulfate de dextrane sont utilisés sous forme de principe actif.
Speert David P.
Usher Thomas C.
Novadex Pharmaceuticals Limited
Torys Llp
University Of British Columbia
LandOfFree
A method of preventing or reducing the risk of infection by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A method of preventing or reducing the risk of infection by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method of preventing or reducing the risk of infection by... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486631